Dr mohammed auwal Ibrahim

Associate Professor,  Ahmadu Bello University, Zaria 

Location: Nigeria

Consulting Services

Journal Manuscript Scientific Writing Grant Submission Research Consulting Data Science-Bioinformatics Conferences

Areas Of Interest

Drug Discovery Biotherapies Molecular Biology Bioinformatics enzymology Medicinal Plants Testing, Preclinical Bioactive Compounds, Plant Computational Biology Molecular Docking Analyses Molecular Dynamics Simulation

Professional Narrative

Mohammed Auwal Ibrahim is an Associate Professor of Biochemistry at Ahmadu Bello University, Zaria, Nigeria. He obtained his PhD from University of KwaZulu-Natal, South Africa followed by a postdoctoral fellowship at University of Pretoria, South Africa (2 years) and another fellowship of the Japan Society for the Promotion of Science (JSPS) conducted at National Institute for Advanced Industrial Science and Technology, Tsukuba, Japan for 1.5 years. His research is mainly focused on the molecular biology, biotherapeutics, drug design and discovery targeting trypanosomiasis, malaria and type 2 diabetes which culminated into >100 scientific articles and >40 presentations at conferences/seminars in different parts of the globe. Dr. Ibrahim has provided leadership by successfully supervising 12 MSc and 3 PhD candidates to completion. In 2018, he was awarded the Young Scientist Program fellowship of the International Union of Biochemistry and Molecular Biology at Seoul, South Korea. He also received travel grants of the American Society for Cell Biology in collaboration with Carnegie Corporation of New York as well as travel grants from United States National Academies of Science, Engineering and Medicine, World Conference on Research Integrity among others. He was also a recipient of competitive doctoral grants from University of KwaZulu Natal, Institution-based research grant from TETFUND, Nigeria and National Research Foundation (NRF) grant by TETFUND, Nigeria, as the principal investigator. He is currently the President of the Nigerian Young Academy (2021 – 2023), a fellow of African Science Literacy Network and an editor/reviewer to many international journals. He is greatly involved in science communication and public engagement for scientific awareness using radio programmes, webinars and online magazines/newspapers publications.

 


Employment

Associate Professor of Biochemistry, Ahmadu Bello University 2020

Education

PhD Biochemistry, University of KwaZulu-Natal, South Africa 2014
PostDoctoral Fellowship, University of Pretoria South Africa 2018
JSPS PostDoctoral Fellowship, AIST, Tsukuba 2021

Referees

Prof. Abdullahi Sallau, Ahmadu Bello University.

“Professor”


June Serem, University of Pretoria.

“Dr”


Publications

20. Ibrahim, M. A., Musa, A. M., Aliyu, A. B., Mayaki, H. S., Gideon A. and Islam, M. S. (2013). Phenolics rich fraction of Khaya senegalensis stem bark: antitrypanosomal activity and amelioration of some parasite-induced pathological changes. Pharmaceutical Biology. 51(7): 906-913. DOI: 10.3109/13880209.2013.771191. (Published by Taylor and Francis Group, (www.tandfonline.com) Informa Limited, UK)

21. Ibrahim M. A., Aliyu A. B., Abdullahi H., Solomon T., Toko E., Garba A., Bashir M. and Habila N. (2013). Lactones rich fraction from Vernonia blumeoides: antitrypanosomal activity and amelioration of the parasite-induced anemia and organ damage. Journal of Natural Medicines.  67(4):750-757. DOI 10.1007/s11418-012-0737-9. (Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

 

22. Aliyu A B. Ibrahim, M. A., Musa A. M., Musa A. O., Kiplimo J. J. and Oyewale A. O. (2013). Free radical scavenging and total antioxidant capacity of root extracts of Anchomanes difformis Engl (Areceae). Acta Poloniae Pharmaceutica. 70(1): 115-121. (Published by the Polish Pharmaceutical Society, Dluga 16, 00-238 Warszawa, Poland http://www.ptfarm.pl/?pid=33))

  

23. Ibrahim M. A., Aliyu A. B., Meduteni K. and Yunusa I. (2013). Saponins-rich fraction of Calotropis procera leaves elicit no antitrypanosomal activity in a rat model. Asian Pacific Journal of Tropical Biomedicine. 3(7): 569-572. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

24. Chipiti T., Ibrahim M. A., Koorbanally, N. A. and Islam M. S. (2013). In vitro antioxidant activities of leaf and root extracts of Albizia antunesiana harms. Acta Poloniae Pharmaceutica. 70(6): 1035-1043. (Published by the Polish Pharmaceutical Society, Dluga 16, 00-238 Warszawa, Poland http://www.ptfarm.pl/?pid=33))

 

25. Isah M. B. and Ibrahim M. A. (2014). The role of antioxidants treatment in the pathogenesis of malarial infections: A review. Parasitology Research. 113: 801-809. DOI 10.1007/s00436-014-3804-1. (Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

 

26. Mohammed A., Ibrahim M. A. and Islam, M. S. (2014). African medicinal plants with anti-diabetic potentials: a systematic review. Planta Medica. 80: 354-377 DOI.org/10.1055/s-0033-1360335. (Published by Thieme Medical Publishers, Georg Thieme Verlag Kg, RudigerstraBe 14, Stuttgart, Germany http://www.thieme.com/books-main/biochemistry/product/3494-planta-medica)).

 

27. Ibrahim M. A. and Islam M. S. (2014). Anti-diabetic effects of the acetone fraction of Senna singueana stem bark in a type 2 diabetes model of rats. Journal of Ethnopharmacology. 153: 392-399. DOI: 10.1016/j.jep.2014.02.042. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

28. Ibrahim M. A., Mohammed A., Isah M. B. and Aliyu A. B. (2014). Anti-trypanosomal activity of African medicinal plants: A review update. Journal of Ethnopharmacology. 154: 26-54. .DOI.org/10.1016/j.jep.2014.04.012 .  (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

29. Habila N., Muhammad A., Aimola, I. A., Chechet G. D., Ibrahim M. A., Kwanashie J. A.,Oche O. E. and Odunola O. A. (2014). Trypanosoma brucei brucei infected rats: micronucleated polychromatic erythrocytes. Tropical Biomedicine. 31(2): 312-319. (Published by Malaysian Society of Parasitology and Tropical Medicine (www.msptm.org),  Institute for Medical Research, Jalan Pahang, Kuala Lumpur, Malaysia)

 

 

30. Ibrahim M. A. and Islam M. S. (2014). Butanol fraction of Khaya senegalensis root modulates β-cell function and ameliorates diabetes-related biochemical paramaters in a type 2 diabetes rat model. Journal of Ethnopharmacology. 154: 832-838. DOI: http://dx.doi.org/10.1016/j.jep.2014.05.011. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

31. Ibrahim M. A., Koorbanally N. and Islam M. S. (2014). Anti-oxidative activity and inhibition of key enzymes linked to type 2 diabetes (α-glucosidase and α-amylase) by Khaya senegalensis. Acta Pharmaceutica. 64: 311-324. (Published by the Croatian Pharmaceutical Society, Croatia http://acta.pharmaceutica.farmaceut.org/)).

 

32. Chipiti T., Ibrahim, M. A., Koorbanally N. A. and Islam M. S. (2015). In vitro antioxidant activity and GC-MS analysis of the ethanol and aqueous extracts of Cissus cornifolia (Baker) Splanch (Vitaceae) parts. Acta Poloniae Pharmaceutica. 72(1): 119-127. (Published by the Polish Pharmaceutical Society, Dluga 16, 00-238 Warszawa, Poland http://www.ptfarm.pl/?pid=33))

 

33. Ibrahim M. A., Aliyu A. B., Musa A. M., Yunusa I., Alexander B., Omogoye F. M. and Musa B. (2015). Effects of α-tocopherol on the in vivo antitrypanosomal effects of phenolic rich fraction of Khaya senegalensis stem bark. Asian Pacific Journal of Tropical Disease.  5(6): 441-444. doi:10.1016/S2222-1808(15)60811-8. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

34. Muhammad A., Odunola O. A., Gbadegesin M. A., Owumi S. E., Sallau A. B., Ndidi U. S. and Ibrahim M. A. (2015). Effects of sodium arsenite and acacia honey on acetylcholinesterase activity in Wistar rats. International Journal of Alzheimer’s Disease. 2015: 903603 http://dx.doi.org/10.1155/2015/903603.

 

35. Chipiti T., Ibrahim M. A., Singh M. and Islam MS (2015). In vitro α-amylase and α-glucosidase inhibitory effects and cytotoxic activity of Albizia antunesiana extracts. Pharmacognosy Magazine. 11(44): S231-S236. (Published by Pharmacognosy Network Worldwide and Medknow Publications (www.medknow.com))

 

36. Musa A. M., Tajuddeen N., Idris A. Y., Rafindadi A.Y., Abdullahi M. I., Aliyu, A. B., Abdullahi M. S., and Ibrahim M. A. (2015). A new antimicrobial prenylated benzo-lactone from the rhizome of Cissus cornifolia. Pharmacognosy Research. 7(4): 363-366. (Published by Pharmacognosy Network Worldwide and Medknow Publications (www.medknow.com))

 

37. Ibrahim M. A., Abdulkadir A., Onojah A., Sani L., Adamu A. and Abdullahi H. (2016). Modulation of sialic acid levels among some organs during insulin resistance or hyperglycemic states. Molecular and Cellular Biochemistry. 411 (1-2): 235-239. DOI 10.1007/s11010-015-2585-x. (Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

 

38. Muhammad A., Odunola O. A., Ibrahim M. A., Sallau A. B., Erukainure O. L., Aimola I. A., Malami I. (2016). Potential biological activity of acacia honey. Frontiers in Bioscience. Elite. 8: 351-357.

 

39. Muhammad A., Ibrahim M. A., Erukainure O. L., Habila N., Idowu A. A., Ndidi U. S., Malami I., Zailani H., Kudan B. Z. and Muhammad B. A. (2016). Induction of haemolysis and DNA fragmentation in a normal and malarial-infected blood by commonly-used antimalarial drugs in the North-Western region of Nigeria. Drug Metabolism Letters. 10: 49-55. (Published by Bentham Science Publishers, (www.benthamscience.com).

 

40. Ibrahim M. A., Habila J. D., Koorbanally N. A. and Islam M. S. (2016). Butanol fraction of Parkia biglobosa leaves enhance pancreatic β cell functions, stimulates insulin secretion and ameliorates other type 2 diabetes-associated complications in rats. Journal of Ethnopharmacology. 183: 103-111. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

41. Ibrahim M. A., Isah M. B. and Abdullahi A. S. (2016). Antioxidant therapy against trypanosome infections: a review update. Current Topics in Medicinal Chemistry. 16: 2233-2244 doi; 10.2174/1568026616666160413125622 . (Published by Bentham Science Publishers, (www.benthamscience.com).

 

42. Ibrahim M. A., Yunusa I., Kabir N., Baba S. A., Yushau A. M., Ibrahim S. S., Bello Z. I., Suleiman S. H., Isah M. B. (2016). In vivo maltase and sucrase inhibitory activities of five underutilized Nigerian edible fruits. Mediterranean Journal of Nutrition and Metabolism. 9: 37-45. DOI: 10.3233/MNM-160057

 

43. Isah M.B., Ibrahim M. A., Mohammed A., Aliyu A. B., Masola B. and Coetzer H.T. (2016). A systematic review of pentacyclic triterpenes and their derivatives as chemotherapeutic agents against tropical parasitic diseases: a review. Parasitology. 143(10): 1219-1231. doi: 10.1017/S0031182016000718. (Published by Cambridge University Press, University Printing House, Cambridge CB2 8BS, United Kingdom, (www.cambridge.org)

 

44. Ibrahim M. A., Koorbanally N. and Islam M. S. (2016). Anti-oxidative, α-glucosidase and α-amylase inhibitory activity of Vitex doniana: possible exploitation in the management of type 2 diabetes. Acta Poloniae Pharmaceutica. 73(5) : 1235-1247. (Published by the Polish Pharmaceutical Society, Dluga 16, 00-238 Warszawa, Poland http://www.ptfarm.pl/?pid=33))

 

45. Muhammad A., Ibrahim M. A., Erukainure O. L., Malami I., Sani H., and Mohammed H. A. (2016). Metabolism and toxicological implications of commonly used chemopreventive drugs against breast cancer/carcinogenesis. Current Drug Metabolism. 17: 930-936. (Published by Bentham Science Publishers, (www.benthamscience.com).

 

46. Chukwuma C. I., Ibrahim M. A. and Islam, M. S. (2016).  Myo-inositol inhibits glucose absorption and promotes muscle glucose uptake: a dual approach study. Journal of Physiology and Biochemistry. 72(4): 791 -801. (Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

 

47. Ibrahim M. A. and Islam, M. S. (2017). Effects of butanol fraction of Ziziphus mucronata root ethanol extract on glucose homeostasis, serum insulin and diabetes-related parameters in a murine model for type 2 diabetes. Pharmaceutical Biology. 55(1): 416-422. DOI: 10.1080/13880209.2016.1242632. (Published by Taylor and Francis Group, (www.tandfonline.com) Informa Limited, UK)

 

48. Muhammad A., Ibrahim M. A., Mohammed H. A., Erukainure O. L., Malami I., Suleiman A., Mansir A., Godwin A. and Khalil H. A. (2017). Alteration of redox status by commonly used antimalarial drugs in the North-Western region of Nigeria. Human and Experimental Toxicology. 36(2): 176-183. DOI:10.1177/0960327116641735. (Published by SAGE journals publishers, SAGE publications, USA http://journals.sagepub.com/ )

 

49.  Chukwuma C. I., Ibrahim M. A. and Islam, M. S. (2017). Maltitol inhibits small intestinal glucose absorption and increases insulin mediated muscle glucose uptake ex vivo but not in normal and type 2 diabetic rats. International Journal of Food Science and Nutrition. 68(1):73-81.  DOI: doi.org/10.1080/09637486.2016.1216527. (Published by Taylor and Francis Group, (www.tandfonline.com) Informa Limited, UK)

 

50. Aminu R., Umar I. A., Rahman M. A. and Ibrahim M. A. (2017). Stigmasterol retards the proliferation and pathological features of Trypanosoma congolense infection in rats and inhibits trypanosomal sialidase in vitro and in silico. Biomedicine and Pharmacotherapy. 89: 482-489. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

51. Ibrahim M. A., Musa A. M., Tairu H. T., Kassim M., Aliyu A. B. Tajuddeen N. Abdullahi H. L. and Habila N. (2017). Combination therapy of vitamin C and phenolics-rich fraction of Khaya senegalensis stem bark extract against Trypanosoma brucei brucei infection in rats. Synergy. 4: 19-22. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

52. Aminu R., Ibrahim M. A., Rahman M. A., Dash R. and Umar I. A. (2017). Trypanosuppresive effects of ellagic acid and amelioration of the trypanosome-associated pathological features coupled with inhibitory effects on trypanosomal sialidase in vitro and in silico. Phytomedicine. 30: 67-73. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

53. Ibrahim M. A., Habila J. D., Koorbanally N. A. and Islam M. S. (2017). α -Glucosidase and α-amylase inhibitory compounds from three African medicinal plants: an enzyme kinetics approach. Natural Product Communications. 12(7): 1125-1128. (Published by SAGE journals publishers, SAGE publications, USA http://journals.sagepub.com/ )

 

 

54. Chipiti T., Ibrahim M. A., Singh M. and Islam MS (2017). In vitro α-amylase and α-glucosidase inhibitory and cytotoxic activities of Cissus cornifolia Planch parts extracts. Pharmacognosy Magazine. 13(2): S329-S333. (Published by Pharmacognosy Network Worldwide and Medknow Publications (www.medknow.com))

 

55. Ibrahim M. A., Bester M.J., Neitz A.W.H. and Gaspar A. R. M. (2018). Structural properties of bioactive peptides with α-glucosidase inhibitory activity: a review. Chemical Biology and Drug Design. 91(2): 370 -379. DOI: 10.1111/cbdd.13105. (Published by John Wiley & Sons, Inc, Hoboken, NJ 07030-5774, New Jersey, USA (www.onlinelibrary.wiley.com))

 

56. Tajuddeen N., Isah M. B., Suleiman M. A., Van Herdeen F. and Ibrahim M. A. (2018). The chemotherapeutic potentials of chalcones against leishmaniasis: a review update. International Journal of Antimicrobial Agents. 51: 311-318.  DOI: 10.1016/j.ijantimicag.2017.06.010. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

57. Muhammad A., Ibrahim M. A., Erukainure O.L., Malami I. and Adamu A. (2018). Spices with breast cancer chemopreventive and therapeutic potentials: A functional foods-based review. Anticancer Agents in Medicinal Chemistry. 18(2): 182 – 194. DOI: 10.2174/1871520617666170912121422. (Published by Bentham Science Publishers, (www.benthamscience.com).

 

58. Ibrahim, M. A., Isah M. B., Abdulwahab N., Kabir N., Maigatari U. M., Gezawa I. D., Salman A. A., Yunusa I. and Muhammad A. (2018). Relationship between hyperglycemic states and glucose-6-phosphate dehydrogenase activity among patients with type 2 diabetes in Kano, Nigeria. Comparative Clinical Pathology. 27(1): 249 -252. DOI: 10.1007/s00580-017-2573-5. ((Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

 

59. Ibrahim M. A., Bester M.J., Neitz A.W.H. and Gaspar A. R. M. (2018). Rational in silico design of α-glucosidase inhibitory peptides and in vitro evaluation of promising candidates. Biomedicine and Pharmacotherapy. 107: 234 -242. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

60.  Ibrahim M. A., Serem J.C., Bester M.J., Neitz A.W.H. and Gaspar A. R. M. (2019). Multiple antidiabetic effects of three α-glucosidase inhibitory peptides, PFP, YPL and YPG: Dipeptidyl peptidase–IV inhibition, suppression of lipid accumulation in differentiated 3T3-L1 adipocytes and scavenging activity on methylglyoxal. International Journal of Biological Macromolecules. 122: 104 - 114. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

61. Ibrahim M. A., Bester M.J., Neitz A.W.H. and Gaspar A. R. M. (2019). Tuber storage proteins as potential precursors of bioactive peptides: an in silico analysis. International Journal of Peptide Research and Therapeutics.. 25(2): 437 – 446.  doi.org/10.1007/s10989-018-9688-7. (Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

 

62. Chukwuma C. I., Matsabisa M. G., Ibrahim M. A., Erukainure O. L., Chabalala M. H. and Islam M. S. (2019). Medicinal plants with concomitant anti-diabetic and anti-hypertensive effects as potential sources of dual acting therapies against diabetes and hypertension: a review. Journal of Ethnopharmacology. 235: 329 – 360. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

63. Abubakar M., Onyike E. and Ibrahim M. A. (2019). In vitro and in vivo studies on the alpha glucosidase inhibitory effects of the leaf extract of Carica papaya Linn. Comparative Clinical Pathology. 28: 1061 – 1067. DOI:  /doi.org/10.1007/s00580-019-02928-9. (Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

  

64. Mchunu N., Chukwuma C. I., Ibrahim M. A., Olajumoke O. and Islam M. S. (2019). Commercially available non-nutritive sweeteners modulate the anti-oxidant status of type 2 diabetic rats. Journal of Food Biochemistry. 43(3): e12775. (Published by John Wiley & Sons, Inc, Hoboken, NJ 07030-5774, New Jersey, USA (www.onlinelibrary.wiley.com))

 

65. Ibrahim M. A., Isah M. B., Tajuddeen N., Hamza S. A. and Mohammed A. (2019). Interaction of stigmasterol with trypanosomal uridylyl transferase, farnesyl diphosphate synthase and sterol 14α-demethylase: an in silico prediction of mechanism of action. Letters in Drug Design and Discovery. 16: 799-807. DOI : 10.2174/1570180815666180711110324. (Published by Bentham Science Publishers, (www.benthamscience.com).

 

66. Ibrahim M. A., Serem J.C., Bester M.J., Neitz A.W.H. and Gaspar A. R. M. (2019). Structure – function analysis of peptide analogs of SQSPA with respect to α-glucosidase and α-amylase inhibition. Protein and Peptide Letters. 29:403–413 doi: 10.2174/0929866526666190327121731. (Published by Bentham Science Publishers, (www.benthamscience.com).

 

67. Saad B. S., Ibrahim M. A., Jatau I. D. and Shuaibu M. N. (2019). Trypanostatic activity of geranylacetone: mitigation of Trypanosoma congolense associated pathological pertubations and insight into the mechanism of anaemia amelioration using in vitro and in silico models. Experimental Parasitology. 201: 49-56. doi: 10.1016/j.exppara.2019.04.011. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

68. Bako H. S., Ibrahim M. A., Isah M. S. and Ibrahim S. (2019). Inhibition of JAK-STAT and Nf-κB signaling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes. Life Sciences. 239: 117045. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

69. Mohammed A., Ibrahim M. A., Tajuddeen N., Aliyu A.B. and Isah M. B. (2020). Antidiabetic potential of anthraquinones. A review. Phytotherapy Research. 34 (3): 486-504 doi: 10.1002/ptr.6544 (Published by John Wiley & Sons, Inc, Hoboken, NJ 07030-5774, New Jersey, USA (www.onlinelibrary.wiley.com))

 

70. Ibrahim M. A., Serem J.C., Bester M.J., Neitz A.W.H. and Gaspar A. R. M. (2020). New antidiabetic targets of α-glucosidase inhibitory peptides, SVPA, SEPA, STYV and STY: Inhibitory effects on dipeptidyl peptidase-IV and lipid accumulation in 3T3-L1 differentiated adipocytes with scavenging activities against methylglyoxal and reactive oxygen species. International Journal of Peptide Research and Therapeutics. 26(4): 1949 – 1963. Published online first   https://doi.org/10.1007/s10989-019-09993-2 (Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

 

71. Ibrahim, M.A., Serem, J.C., Bester, M.J., and Gaspar A.R.M., (2020). The dipeptidyl peptidase IV inhibitory activity and multifunctional antidiabetic properties of SQSPA: Structure-Activity relationship evaluated with alanine scanning. International Journal of Biological Macromolecules. 160: 1220 – 1229 (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

72. Saad, B.S., Ibrahim, M.A., Jatau, I.D., Shuaibu, M.N., (2020). The therapeutic potential of phytol towards Trypanosoma congolense infection and the inhibitory effects against trypanosomal sialidase,” Experimental Parasitology, 216: 107943 (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

73. Ibrahim M. A., Atilola O., Mohammed A., Awosanya E. J., Odetokun I. A., Muhammad A., Chukwudi C. U., Ukwaja K. N. and Oyeyemi O. T. (2020) Cerebral Malaria and                 Toxoplasmosis: Could their concomitant presentation worse psychotic condition?. Annals of Science and Technology. 5(2): 24 -39. (Published by the Nigerian Young Academy and Sciendo (formerly De Gruyter) (https://www.sciendo.com/about-us), Poland).

 

74. Olatunde A., Mohammed A., Ibrahim M. A., Shuaibu M.N. (2020) Influence of methoxylation on the anti-diabetic activity of p-hydroxybenzaldehyde in a type 2 diabetic rat model.             Phytomedicine Plus. 1: 100003 (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

75. Usman, M.A., Ibrahim M.A., Salman, A.A., and Sallau, A. B. (2020). Depletion of cholesterol could be associated with modulation of progesterone but not other sex hormones levels during Plasmodium falciparum infection in humans: a cross-sectional study from Zaria, Nigeria. Parasitology Research. 119: 4143-4150. (Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

 

76. Adamu, A., Jada, M. S., Haruna, H. M. S., Yakubu B. O., Ibrahim, M. A., Balogun E.O., Sakura T., Inaoka D. K., Kita, K., Hirayama, K., Culleton R and Shuaibu M. N. (2020).Plasmodium falciparum multidrug resistance gene-1 polymorphisms in Northern Nigeria: Implications for the continued use of artemether-lumefantrine in the region. Malaria Journal. 19: 439 (Published by Biomed Central (BMC), Part of Springer Nature, (https://www.biomedcentral.com/about), USA).

 

77. Alhafiz Z. A., Abdulsalami M. S., Ibrahim M. A., Bulus T. and Babangida S. A. (2020). Molecular identification of Trypanosoma brucei brucei  and in vitro antitrypanosomal activity of different parts of methanolic extract of Senna occidentalis. Clinical Phytoscience. Published Online  DOI: 10.1186/s40816-020-00178-9

 

78. Mohammed A., Awolola G. V., Ibrahim M. A., Koorbanally N. and Islam M. S. (2021). Oleanolic acid as active antidiabetic component of Xylopia aethiopica (Annonaceae) fruit: Bioassay guided isolation and molecular docking studies. Natural Products Research. 35(5): 788-791. DOI: https://doi.org/10.1080/14786419.2019.1596094 (Published by Taylor and Francis Group, (www.tandfonline.com) Informa Limited, UK)

 

79. Inim M. D., Ibrahim, M. A., Isah M. B. and Onyike E. (2021). Variations in the mRNA expression level of UDP-GlcNAc epimerase/ManNAc kinase and neuraminidase I genes in organs of type 2 diabetic animals. Glycoconjugate Journal. 38 (1): 129 -139. (Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

 

 

80. Usman M. A., Usman F. I., Abubakar M. S., Salman A. A., Adamu, A. and Ibrahim M. A. (2021), Phytol suppresses parasitemia and ameliorates anaemia and oxidative brain damage in mice infected with Plasmodium berghei. Experimental Parasitology. 224: 108097 (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

81. Abdelfattah M.A.O., Ibrahim M. A., Abdullahi H. L., Aminu R., Saad S. B., Krstin S., Wink M. and Sobeh M. (2021). Eugenia uniflora and Syzigium samarangense extracts exhibit anti-trypanosomal activity: Evidence from in silico molecular modeling, in vitro and in vivo studies. Biomedicine and Pharmacotherapy, 138: 111508 (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

82. Adamu R. M., Singh R. M., Ibrahim M. A., and Uba A. I. (2021). Virtual discovery of a heterocyclic compound from the Universal Natural Product Database (UNDP36) as a potential inhibitor of interleukin-33: Molecular docking and dynamic simulations. Journal of Biomolecular Structure and Dynamics. Online First version. doi: 10.1080/07391102.2021.1915180 (Published by Taylor and Francis Group, (www.tandfonline.com) Informa Limited, UK).

 

83. Adamu R. M., Ibrahim B., Ibrahim M. A. and Balogun E. O. (2021). Identification of megacerotonic acid and a quinazoline derivative from Universal Natural Product Database as potential inhibitors of Trypanosoma brucei brucei alternative oxidase: molecular docking, molecular dynamic simulation and MM/PBSA analysis. Journal of Biomolecular Structure and Dynamics. Published Online First doi: 10.1080/07391102.2021.2003862 (Published by Taylor and Francis Group, (www.tandfonline.com) Informa Limited, UK).

 

84. Ika M.D., Ibrahim M. A., Sallau A. B., Salman A. A., Sani A. M. and Isah M. B. (2022). Variations in the serum sialic acid profiles of malaria patients in Zaria, Nigeria: A cross-sectional study. Acta Parasitologica. Published Online First doi: 10.1007/s11686-021-00503-3 (Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

 

85. Abdulrashid N. I., Aminu S., Adamu R. M., Tajuddeen N., Isah M. B., Jatau I. D., Aliyu A. B., Simelane M. B. C., Onyike E. and Ibrahim M. A. (2022). Phrologlucinol as a potential candidate against Trypanosoma congolense infection: Insights from in vivo, in vitro, molecular docking and molecular dynamic simulation analyses. Molecules. 27:469. https://doi.org/10.3390/molecules27020469  (Published by MDPI publishers, Basel, Switzerland).

 

86. Audu F. E., Usman M. A., Raphaeal F. N., Abdulmutallab A., Jimoh F. M. and Ibrahim M. A. (2022). High carbohydrate diet lacked the potential to ameliorate parasitemia and oxidative stress in mice infected with Plasmodium berghei. Parasitology Research. 121(2):737-742.

 

87. Aminu S., Ibrahim M.A., Chechet G.D., Onyike E (2022). Chemotherapeutic potentials of β-ionone against Trypanosoma congolense infection: Inhibition of parasite proliferation, anemia development, trans-sialidase (TconTS3 and TconTS4) gene expressions, and phospholipase A2. Chemical Biology and Drug Design. 99(6): 908-922. doi: 10.1111/cbdd.14048. (Published by John Wiley & Sons, Inc, Hoboken, NJ 07030-5774, New Jersey, USA (www.onlinelibrary.wiley.com))

 

88. Ibrahim, M. A., Yamasaki T., Furukawa, K. and Yamasaki K. (2022). Fragment-Based Drug Discovery for Trypanosoma brucei Glycosylphosphatidylinositol-Specific Phospholipase C through Biochemical and WaterLOGSY-NMR Methods. The Journal of Biochemistry. 171(6):619-629. doi: 10.1093/jb/mvac020 (Published by Oxford University Press, United Kingdom)

 

89. Mohammed A, Tajuddeen N, Ibrahim M.A., Isah MB, Aliyu AB, Islam MS. (2022) Potential of diterpenes as antidiabetic agents: Evidence from clinical and pre-clinical studies. Pharmacological Research. 179:106158. doi: 10.1016/j.phrs.2022.106158. (Published by Elsevier B. V. (www.elsevier.com), The Netherlands).

 

90. Aminu S, Danazumi AU, Alhafiz ZA, Gorna MW, Ibrahim M.A. (2022). β-Sitosterol could serve as a dual inhibitor of Trypanosoma congolense sialidase and phospholipase A2: in vitro kinetic analyses and molecular dynamic simulations. Molecular Diversity. doi: 10.1007/s11030-022-10517-2. (Published by Springer International Publishing (www.springer.com) Heidelberg, Germany).

91. Adeosun IJ, Baloyi I, Aljoundi AK, Salifu EY, Ibrahim M.A., Cosa S. (2022). Molecular modelling of SdiA protein by selected flavonoid and terpenes compounds to attenuate virulence in Klebsiella pneumoniae. Journal of Biomolecular Structure and Dynamics. 23:1-19. doi: 10.1080/07391102.2022.2148753. (Published by Taylor and Francis Group, (www.tandfonline.com) Informa Limited, UK).


Grants,Awards and Certifications

Grants :

  1. I was awarded a Competitive Doctoral Research Grant from the Research office, University of Kwazulu Natal (Westville campus), Durban. South Africa in 2011.
  1. I was awarded a PhD study scholarship by the Education Trust Fund of Nigeria (ABU-Desk office) in 2011.
  1. I was awarded an International conference travel grant by the Faculty of Science and Agriculture, University of KwaZulu Natal, South Africa in 2011.

 

  1. I was awarded a doctoral bursary (research grant and living expenses) by the College of Agriculture, Engineering and Sciences, University of KwaZulu Natal, South Africa in 2012.

 

  1. I was awarded an international travel grant award by the American Society for Cell Biology to attend the 2014 ASCB/IFCB meeting in Philadelphia, USA.

 

  1. I was awarded a University of Pretoria Postdoctoral fellowship award by the Department of Research and Innovation, University of Pretoria to conduct research at the Biotherapeutics Research Group, Department of Biochemistry, University of Pretoria, Hatfield Campus, South Africa

 

  1. I was awarded the Young Scientist Program fellowship to attend the 2018 congress of the International Union of Biochemistry and Molecular Biology scheduled to hold Seoul, South Korea in June, 2018.

 

  1. I was awarded an Institutional Based Research Grant by the Tertiary Education Fund, Nigeria (N1, 728, 906.00) as the principal investigator for research on the “Novel peptide-based Dipeptidyl peptidase IV (DPP-IV) inhibitors from some indigenous Nigerian tubers for the management of type 2 diabetes”.

 

  1. I was awarded a Japan Society for the Promotion of Science (JSPS) research fellowship tenable at the National Institute for Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.

 

  1. I was awarded the 2020 TETFUND National Research Fund Grant (N27, 960, 542.00) as the principal investigator for research on the “Development of Recombinant Metarhizium anisopliae chitinase as a mosquitocidal agent for the control of Malaria”.
  2. I was awarded the travel grant by the World Conference on Research Integrity to attend the World Conference on Research Integrity at Cape Town, South Africa (May, 2022)
  3. I was awarded the travel grant of the US National Academy of Science, Engineering and Medicine to attend and participate at the Triennial Conference of the InterAcademy Partnership (IAP) and the Worldwide Meeting of the Young Academies at the BioSphere 2 in Tucson, Arizona, United States of America in November 2022.

Awards & Prizes :

  1. I was awarded a Competitive Doctoral Research Grant from the Research office, University of Kwazulu Natal (Westville campus), Durban. South Africa in 2011.
  1. I was awarded a PhD study scholarship by the Education Trust Fund of Nigeria (ABU-Desk office) in 2011.
  1. I was awarded an International conference travel grant by the Faculty of Science and Agriculture, University of KwaZulu Natal, South Africa in 2011.

 

  1. I was awarded a doctoral bursary (research grant and living expenses) by the College of Agriculture, Engineering and Sciences, University of KwaZulu Natal, South Africa in 2012.

 

  1. I was awarded an international travel grant award by the American Society for Cell Biology to attend the 2014 ASCB/IFCB meeting in Philadelphia, USA.

 

  1. I was awarded a University of Pretoria Postdoctoral fellowship award by the Department of Research and Innovation, University of Pretoria to conduct research at the Biotherapeutics Research Group, Department of Biochemistry, University of Pretoria, Hatfield Campus, South Africa

 

  1. I was awarded the Young Scientist Program fellowship to attend the 2018 congress of the International Union of Biochemistry and Molecular Biology scheduled to hold Seoul, South Korea in June, 2018.

 

  1. I was awarded an Institutional Based Research Grant by the Tertiary Education Fund, Nigeria (N1, 728, 906.00) as the principal investigator for research on the “Novel peptide-based Dipeptidyl peptidase IV (DPP-IV) inhibitors from some indigenous Nigerian tubers for the management of type 2 diabetes”.

 

  1. I was awarded a Japan Society for the Promotion of Science (JSPS) research fellowship tenable at the National Institute for Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.

 

  1. I was awarded the 2020 TETFUND National Research Fund Grant (N27, 960, 542.00) as the principal investigator for research on the “Development of Recombinant Metarhizium anisopliae chitinase as a mosquitocidal agent for the control of Malaria”.
  2. I was awarded the travel grant by the World Conference on Research Integrity to attend the World Conference on Research Integrity at Cape Town, South Africa (May, 2022)
  3. I was awarded the travel grant of the US National Academy of Science, Engineering and Medicine to attend and participate at the Triennial Conference of the InterAcademy Partnership (IAP) and the Worldwide Meeting of the Young Academies at the BioSphere 2 in Tucson, Arizona, United States of America in November 2022.


Languages

Language Proficiency :

English (Excellent Spoken and Written)

Translation Services :